KPP Advisory Services LLC Grows Holdings in Intuitive Surgical, Inc. $ISRG

Key Points

• KPP Advisory Services LLC increased its holdings in Intuitive Surgical, Inc. by 48.1% during the second quarter, bringing its total shares to 2,057 valued at approximately $1,118,000.
• Institutional investors now own 83.64% of Intuitive Surgical's stock, with significant increases in holdings reported by firms such as Nuveen LLC and Goldman Sachs Group Inc.
• Intuitive Surgical's stock has garnered positive analyst attention, with multiple firms raising their price targets, and it currently holds an average rating of "Moderate Buy" among analysts.

KPP Advisory Services LLC boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 48.1% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,057 shares of the medical equipment provider's stock after acquiring an additional 668 shares during the period. KPP Advisory Services LLC's holdings in Intuitive Surgical were worth $1,118,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the business. Nuveen LLC purchased a new stake in shares of Intuitive Surgical in the first quarter worth $1,715,899,000. Goldman Sachs Group Inc. increased its holdings in shares of Intuitive Surgical by 26.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider's stock worth $1,396,496,000 after purchasing an additional 584,375 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Intuitive Surgical by 20.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider's stock worth $1,680,922,000 after purchasing an additional 566,979 shares during the last quarter. Wellington Management Group LLP raised its position in Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider's stock worth $1,732,975,000 after buying an additional 457,080 shares during the last quarter. Finally, Vanguard Group Inc. lifted its position in Intuitive Surgical by 1.4% during the first quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock valued at $16,178,258,000 after purchasing an additional 453,335 shares during the period. Institutional investors own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the sale, the director owned 739 shares of the company's stock, valued at $325,669.91. The trade was a 31.19% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the business's stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares in the company, valued at $9,368,059.23. This represents a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 45,224 shares of company stock valued at $21,716,492 in the last three months. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $530.13 on Thursday. The stock has a market cap of $190.04 billion, a PE ratio of 70.12, a price-to-earnings-growth ratio of 4.86 and a beta of 1.61. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The firm has a fifty day moving average price of $455.28 and a 200-day moving average price of $495.80.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.03%. The company had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the prior year, the firm posted $1.84 EPS. Intuitive Surgical's quarterly revenue was up 22.9% compared to the same quarter last year. On average, research analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analysts Forecast Growth

ISRG has been the subject of a number of research reports. Rothschild & Co Redburn upped their price objective on Intuitive Surgical from $610.00 to $615.00 and gave the company a "buy" rating in a research report on Thursday. Piper Sandler upped their price target on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an "overweight" rating in a research report on Wednesday. Leerink Partners increased their price objective on shares of Intuitive Surgical from $593.00 to $600.00 and gave the stock an "outperform" rating in a research note on Wednesday. Mizuho set a $575.00 target price on shares of Intuitive Surgical in a research report on Wednesday. Finally, Raymond James Financial set a $603.00 price target on shares of Intuitive Surgical and gave the stock an "outperform" rating in a research note on Wednesday. Eighteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $604.50.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.